In an advanced scientific and technological context, where it is now tangible the possibility of interfering indefinitely in the process of dying, it becomes necessary to disseminate knowledge about e
1In colorectal patients panitumimab (immunotherapy) is a well-accepted approach in the third line [42]; in a selection of breast cancer patients, immunotherapy can be the accepted approach, frequently